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Abstract 
Gangliosides are involved in a variety of biological roles and are a component of 
lipid rafts found in cell plasma membranes (PMs). Gangliosides are especially 
abundant in neuronal PMs and are essential to their physiological functions. 
However, the dynamic behaviors of gangliosides have not been investigated in 
living cells due to a lack of fluorescent probes that behave like their parental 
molecules. We have recently developed, using an entirely chemical method, four 
new ganglioside probes (GM1, GM2, GM3, and GD1b) that act similarly to their 
parental molecules in terms of raft partitioning and binding affinity. Using single 
fluorescent-molecule imaging, we have found that ganglioside probes 
dynamically enter and leave rafts featuring CD59, a GPI-anchored protein. This 
occurs both before and after stimulation. The residency time of our ganglioside 
probes in rafts with CD59 oligomers was 48 ms, after stimulation. The residency 
times in CD59 homodimer and monomer rafts were 40 ms and 12 ms, respectively. 
In this review, we introduce an entirely chemical-based ganglioside analog 
synthesis method and describe its application in single-molecule imaging and for 
the study of the dynamic behavior of gangliosides in cell PMs. Finally, we discuss 
how raft domains are formed, both before and after receptor engagement. 
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1. Introduction 
Gangliosides are glycosphingolipids containing one or more sialic acid (N-
acetyl-neuraminic acid) groups. They are particularly abundant in neuronal cell 
plasma membranes (PMs) [1, 2]. More than 40 types of ganglioside have been 
described, with the location and number of sialic acids groups present being 
different in each. Gangliosides containing one, two, three, or four sialic acid 
groups are termed GM, GD, GT, and GQ, respectively. Gangliosides are further 
defined using numbers to indicate their migratory position after thin-layer 
chromatography (e.g., GQ1b, GM3, GD3). Gangliosides are known to have a 
variety of important physiological functions in cell PMs (Fig. 1). For example, they 
are involved in the invasion of microbial toxins [3], viruses [4, 5], and bacteria 
into cells. They have also been shown to regulate membrane receptor activity [6]. 
More specifically, previous studies have indicated that GM3 inhibits activation of 
epidermal growth factor receptors (EGFRs) [7-11]. It has also been reported that 
activation of the nerve growth factor (NGF) receptors (Trk) is enhanced by 
interactions with GM1 [12, 13]. The ganglioside GD3 was found to enhance 
adhesion signaling by recruiting integrins to lipid rafts [14] and GQ1b was found 
to increase tyrosine phosphorylation of N-methyl-d-aspartate (NMDA) subunit 2B, 
which may subsequently enhance NMDA receptor synaptic activation [15]. Finally, 
gangliosides are known to be involved in various infections and the onset of 
several diseases, such as Guillain-Barre syndrome [16-21], Alzheimer’s disease 
[22-25], and gangliosidosis [26-29].  
Through certain interactions with cholesterol, gangliosides are also 
known to be involved in the formation of raft domains found in PMs [30-33]. 
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Interestingly, these lipid rafts facilitate the regulatory effects that gangliosides 
have on receptor activity. For example, inhibition of EGFR activity by GM3 in giant 
unilamellar vesicles (GUVs) is more effective in the presence of liquid ordered 
(Lo) phase regions (raft-like domains) [11]. 
However, gangliosides have not directly been observed in the PMs of 
living cells and previous studies have been performed using fixed PMs or by 
examining how the expression levels of gangliosides affect receptor activities and 
other cellular processes. This is primarily due to the scarcity of fluorescent 
ganglioside probes that behave in a similar manner to the parental molecules. 
Although GM1 analogs have been synthesized that possess alkyl chains or glycans 
bound to fluorophores [34-39], these analogs do not partition into the raft-like 
domains [40]. They also do not bind proteins as strongly as their parental 
ganglioside molecules [38]. To overcome these issues, ganglioside-binding 
proteins, such as cholera toxin subunit B (CTB), are often used to examine the 
location of gangliosides in cells [41-47]. However, these proteins are multivalent 
and can crosslink gangliosides, changing their lateral distribution in the PMs of 
cells [48-51]. Even if PMs are fixed using 4% paraformaldehyde and 0.5% 
glutaraldehyde, a significant fraction of lipid molecules are still mobile [52, 53] 
and  can crosslink ganglioside molecules. Similarly, it is difficult to perform 
immunohistochemical staining of gangliosides as labeling using primary and 
secondary antibodies also results in crosslinking, even after cell fixation. This 
leads to the creation of bright fluorescent patches of gangliosides [52, 53]. Due 
to all of these various factors, it has been extremely difficult to examine the lateral 
distribution of gangliosides in cell PMs. 
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To address this issue, we have used entirely chemical methods [54-60] 
to develop fluorescent ganglioside probes that behave in a similar manner to their 
parental gangliosides [61]. In this review, we provide an overview of the studies 
performed to elucidate the dynamic behaviors of gangliosides in cell PMs. We also 
introduce some of the uses of our new fluorescent probes, such as single-
molecule imaging and understanding how raft domains are formed, both before 
and after receptor engagement. 
 
1.1. Synthesis of ganglioside probes 
As previously described, the synthesis of fluorescently labeled ganglioside 
analogs has been reported by many research groups, primarily GM1. An 
important factor when synthesizing fluorescent analogs of gangliosides is that the 
chemically labile fluorescent dye should be incorporated at a specific position in 
the target molecule. Consequently, dye incorporation must be chemo-selectively 
executed at the final step of synthesis. However, this means that the final 
incorporation will be in the presence of an array of hydroxyl groups. To meet this 
synthetic limitation, a highly reactive functional group needs to be incorporated 
into the ganglioside molecule to act as a specific coupling partner for the 
fluorescent dye reagent. One such method is based on exploiting the endogenous 
amido moieties of sialic acid and ceramide, typically found in gangliosides. These 
two groups are readily converted into free amino groups by basic hydrolysis to 
produce 5-amino-sialic acid and 2-amino-sphingosine containing gangliosides, 
respectively [62]. Several research groups have used this approach to 
successfully incorporate fluorescent dyes at the C5-amino group of sialic acid 
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and/or the C2-amino group of sphingosine (Fig. 2a) [35-37, 63]. 
In addition, Wilchek et al. (1980) developed a selective conversion 
method that changed the glycerol chain of sialic acid into a C7-aldehyde derivative 
[64]. Through taking advantage of the high electrophilicity of this aldehyde group, 
C7-aldehyde gangliosides were able to be conjugated to various amine-
terminated fluorophores (Fig. 2b) [38]. These approaches are described as break-
down (or top-down) methods as they utilize gangliosides isolated from natural 
sources as the starting materials (in almost all cases, these are bovine brain 
matter). However, these methods produce heterogeneous mixtures of fluorescent 
analogs that differ in their chain length due to different sphingosine moieties.  
Alternatively, Rich et al. (2011) showcased de-novo (bottom-up) 
synthesis of homogenous fluorescent ganglioside GM3 using a chemoenzymatic 
method that utilized glycoside hydrolase mutants described as glycosynthases 
[65]. This approach was shown to be tolerant to modified glycosyl donors and 
was suitable for the construction of a C9-azido-lyso-GM3 variant. This underwent 
subsequent chemoselective conjugation with fluorescent dyes, creating a GM3 
molecule with dual fluorescence (Fig. 3) [66]. 
More recently, we have developed novel fluorescent ganglioside probes 
that are useful for studying interactions between lipid rafts and gangliosides in 
PMs using a de-novo chemical synthesis method (Fig. 4) [61]. When designing 
these fluorescent gangliosides, we paid particular consideration to the importance 
of the ceramide (Cer) moiety in the interactions with other membrane lipids and 
cholesterols in the inner and outer leaflets of PMs [67, 68]. By taking this into 
account, we aimed to incorporate fluorescent dyes using the glycan moiety found 
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in gangliosides. To modify linear ganglioside GM3, one of five dyes was attached 
to the central position (position C6 of the inner galactose (Gal) of GM3; position 
G6) and the outermost position (position C9 of sialic acid; position S9). The 
effects of the dye on the physical properties of the ganglioside were examined in 
relation to a preference to incorporate into lipid rafts, referred to as ‘raftphilicity’. 
For GM1, GM2, and GD1b with branched glycans, the outermost positions 
(positions S9 and/or C6 of the terminal sugar residue) were modified with a dye. 
To ultimately realize our fluorescent ganglioside design, we applied our 
previously developed method to the synthesis of gangliosides. This system uses 
a glucosyl ceramide (Glc-Cer) cassette [56, 58-60] and N-Troc-sialyl galactose 
(Neu5Troc-Gal) [54, 69] as the key synthetic units. Neu5Troc-Gal unit 1 (Fig. 5) 
was used as a platform for modifying Neu and Gal moieties with amine-relevant 
substituents to couple the fluorescent dye. 
 
1.1.1. Synthesis of fluorescent GM3 analogs 
Following previously published reports, disaccharide unit 1 was converted 
into a 4,6-diol derivative and further modified with an azide group at the C6 
position to give a C6-azido derivative (Fig. 5). Subsequent conversion with a 
trichloroacetimidate donor gave 2 that was used for the synthesis of the G6 
analogs. For the synthesis of the S9 analogs, the sialic acid moiety of 1 was 
transformed into an N-acetyl tetraol. An azide group was then incorporated at the 
C9 position in a similar manner to that for compound 2. Next, the azide group 
was converted into a trifluoroacetamide (NHTFAc) group, to give compound 3. 
The protecting groups were manipulated to produce the C9-NHTFAc-Neu-Gal 
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donor 4. Neu-Gal donors (2 and 4) and the Glc-Cer acceptor 5 were glycosylated, 
providing high yields of the two ganglioside GM3 frameworks 6 and 7. Following 
global deprotection of 6, the azide was reduced to an amine and reacted with 
the activated ester of a fluorescent dye to create the G6 GM3 analogs (TMR-G6-
GM3 and 594-G6-GM3). In contrast, 7 was converted to a corresponding amino-
GM3 precursor via removal of the p-methoxybenzyl protecting groups and 
subsequent hydrolysis. The fluorescent group was then incorporated at position 
C9 of the sialic acid group to create the S9 GM3 probes (TMR-S9-GM3, Fl-S9-GM3, 
594-S9-GM3, 647N-S9-GM3, and 488-S9-GM3) [61].  
 
1.1.2. Synthesis of fluorescent GM1 analogs 
The synthetic methodology used to create the GM3 analogs was applied 
to the more complex GM1 analogs that contained branched glycan moieties (Fig. 
6). For the synthesis of the S9 GM1 core sequence, C9-NHTFAc Neu-Gal 3 was 
converted into the corresponding glycosyl acceptor 8 via selective protection of 
the hydroxyl groups. Next, 8 was elongated using the disaccharide donor 9 via a 
stereoselective glycosylation reaction [70] to create a branched tetrasaccharide. 
This tetrasaccharide was converted into a glycosyl imidate donor through an 
eight-step manipulation of protecting groups to create 10. In contrast, the 
synthesis of the termG6 GM1 core sequence began with the glycosylation of 
branched trisaccharyl acceptor 11 (previously developed in our group) [59] with 
C6-NHTFAc galacotosyl imidate 12. This resulted in a 92% tetrasaccharide yield. 
Following a procedure similar to that used for the S9 probes, the tetrasaccharide 
was converted to donor 13.  
p. 9 
 
Final coupling of the tetrasaccharides (10 and 13) to Glc-Cer acceptor 5 
led to GM1 ganglioside frameworks 14 and 15, respectively. Similar to the GM3 
analogs, compounds 14 and 15 were subsequently converted into their C9-/C6-
amino forms. These underwent further conjugation with the succinimidyl esters 
of fluorescent dyes to yield the target fluorescent GM1 probes (TMR-S9-GM1, 
594-S9-GM1, 488-S9-GM1, and 594-termG6-GM1) [61]. 
 
1.1.3. Synthesis of fluorescent GM2 analogs 
The S9 GM2 glycan moiety was synthesized using a similar approach to 
that used for S9 GM1 (Fig. 7). C9-NHTFAc-Neu-Gal acceptor 8 was used to 
construct the branched trisaccharide. Disaccharide acceptor 8 was glycosylated 
with N-Troc-galactosaminyl donor 17 [71] and then protecting group 
manipulation resulted in donor 18. For the GN6 analogs, C6-azido-N-
trichloroacetyl-galactosaminyl donor 20 was coupled to Neu-Gal acceptor 19 to 
produce a trisaccharide. Next, the C6-azide group and the C2-trichloroacetyl 
moiety were converted to either an amine or acetamide group, respectively. 
These were then treated with TFAcOMe to produce a C6-NHTFAc derivative. 
Trisaccharide donors (18 and 21) were coupled to Glc-Ce acceptor 5 to create 
the GM2 frameworks 22 and 23. Finally, the protected GM2-analog precursors 
were derivatized to produce ATTO594-conjugated GM2 analogs (594-S9-GM2 and 
594-GN6-GM2) [61]. 
 
1.1.4. Synthesis of the fluorescent GD1b analog 
The b-series ganglioside GD1b contains an α(2,8)-linked disialyl moiety 
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that is particularly difficult to synthetically target due to the low reactivity of 8-
OH. Modification of the sialyl donor, such as by substituting 9-OH with an amide 
group, could greatly decrease stereoselectivity during glycosidation. Therefore, 
we targeted the C6 position of the terminal Gal as the dye loading position. The 
glycan part of GD1b could be disassembled into the C6-NHTFAc galactosyl imidate 
12, which is common to termG6 GM1, and disialic acid-containing tetrasaccharide 
acceptor 24 [56], previously developed by our group (Fig. 8). The coupling of 
donor 12 and acceptor 24 led to a 70% yield of GD1b core pentasaccharide. This 
resulting pentasaccharide was sequentially converted into the imidate derivative 
25 and coupled with the Glc-Cer cassette to yield fully protected GD1b 26. Finally, 
global deprotection and coupling with ATTO594 succinimidyl ester produced 594-
termG6-GD1b [61]. 
     
1.2. Characterization of the new ganglioside probes 
The fluorescent analogs of gangliosides were subjected to biophysical 
evaluation to examine their raftphilicities. The fluorescent analogs were also 
compared to native molecules to assess their affinities to bind sugar-binding 
proteins known to influence dye conjugation and protein recognition. Raft 
markers, such as cholesterol and saturated phospholipids, were preferentially 
partitioned into detergent-resistant membranes (DRMs). These are typically 
insoluble in cold non-ionic detergents. Markers were also partitioned into liquid-
ordered phase-like (Lo-like) domains in giant plasma membrane vesicles (GPMVs). 
These contained the full complement of lipids and proteins found in native PMs, 
except for the actin-based membrane skeleton [56, 72, 73].  
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1.2.1. Analysis of DRM partitioning 
The cold-detergent solubilities of fluorescent gangliosides synthesized in 
the study, in addition to commercially available analogs, were examined in human 
T24 epithelial cells. PMs with pre-incorporated fluorescent ganglioside analogs, 
and other fluorescent lipids, were treated with cold Triton X-100 and observed by 
epifluorescence microscopy [74]. This showed that the S9 (GM3, GM2, and GM1), 
termG6-GM1, GN6-GM2, and termG6-GD1b analogs mainly partitioned into the 
DRMs (Fig. 9a, c). TMR-G6-GM3 and commercially available BodipyFL-C5-GM1 
[75-78], in which a fatty acid chain is substituted with BodipyFL and is widely 
used as a raft marker, solubilized almost completely in detergent, similar to non-
raft markers (BodipyFL-C5-PC, 594-DOPE, and 647N-DOPE) [61]. In the TMR-G6-
GM3 derivative, the hydrophobic dye TMR is attached to position C6 of galactose, 
while in BodipyFL-C5-PC, the hydrophobic dye BodipyFL is attached to the sn-2-
acyl chain via a C5 alkyl chain of PC. For both of these markers, the hydrophobic 
dyes used may hamper their incorporation into DRMs. Analysis of DRM 
partitioning showed that modification using hydrophilic fluorophores at the S9 
position of GM3, including ATTO594, ATTO488, and Fl, retained a preference for 
the DRM partition.  
A discrepancy between the partition patterns of several probes into either 
the DRM or Lo phase was also observed. For example, TMR-G6-GM3 was almost 
completely solubilized in cold-Triton X-100 but had an average Lo/Ld ratio of 1.7. 
This may be due to the fact that these assays were performed in different cell 
types (T24 cells for DRM and RBL-2H3 cells for Lo/Ld) or because Triton X-100 
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promotes domain formation [79]. TMR-G6-GM3 may therefore be segregated 
from these induced domains. 
 
1.2.2. Analysis of Lo-like and Ld-like domain partitioning in GPMVs 
Our examination of the partitioning of fluorescent ganglioside analogs 
into Lo-like and Ld-like domains in GPMVs closely matches previous analyses of 
partitioning in DRMs (Fig. 9b, c) [61]. These results indicated that only 
ganglioside analogs modified using hydrophilic fluorophores at the terminal 
position of the glycan group associated with raft domains, similar to native 
gangliosides. 
 
1.2.3. Binding affinities of sugar-binding proteins 
Surface plasmon resonance (SPR) analysis was used to measure the 
dissociation constants (Kd) between ganglioside analogs and sugar-binding 
proteins. The binding affinities of CTB to fluorescent GM1s, and those of WGA to 
fluorescent GM3s incorporated into 1-palmitoyl-2-oleoyl-sn-
glycerophosphorylcholine vesicles (10 mol %), were determined using SPR 
equilibrium analysis. GM1 and GM3 conjugated with ATTO594 at their S9 positions 
exhibited comparable affinity constants to native molecules for both of the 
ganglioside binding proteins, cholera toxin subunit B (CTB) and wheat germ 
agglutinin (WGA) (Table 1). These results suggest that ATTO594 conjugation at 
the S9 position of GM1 and GM3 did not interfere with CTB binding to GM1, nor 
WGA binding to GM3 [61]. In contrast, the affinity of CTB to a previously 
developed fluorescent GM1 in which Alexa568 has been conjugated to the 
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glycerol side chain of the sialic acid (with the removal of two hydroxyl groups and 
one carbon), was reduced by approximately 10-fold [38]. This difference may be 
due to the location of the dye molecule within the GM1 molecule and/or the 
particular dye used. 
In earlier studies examining the dynamics and functions of gangliosides 
in PMs, fluorescently labeled CTB (e.g., Cy3-CTB) has widely been used as a GM1-
specific marker. However, GM1 molecules labeled using this technique are 
crosslinked, modifying the distribution of gangliosides and their behavior in PMs. 
Single-molecule tracking indicated that Cy3-CTB complexed with GM1 moved with 
smaller diffusion coefficients (0.01–0.06 μm2/s) than any of our fluorescent 
ganglioside analogs (0.31–0.36 μm2/s) or phospholipids (0.20–0.22 μm2/s). This 
was due to the clustering of GM1 molecules after binding to five CTB carbohydrate 
binding pockets. These results clearly show that CTB changes the dynamic 
behavior of GM1. In this context, previously developed fluorescent GM1 probes, 
in which a fluorescent dye was directly attached to the lipid via the fatty acid 
moiety [34-37], have been revealed to be unsuitable markers for lipid rafts. 
Our results have also shown that the most widely used marker, BodipyFL-
C5-GM1 [75-78], is not incorporated into DRMs nor Lo-like phases, although its 
diffusion coefficients are similar to that of our fluorescent gangliosides and 
phospholipids. Dye introduction into the lipid tail moiety may weaken hydrophobic 
interactions with other molecules residing in the DRMs and Lo-like phase. 
Recently, a head group-labeled GM1 probe has been developed, in which 
Alexa568 was conjugated to a shortened side chain of the sialic acid group (one 
carbon and two hydroxyl groups were removed from the glycerol moiety) [38]. 
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However, it exhibited lower affinity to CTB than native molecules (~10-fold less). 
This highlights the importance of retaining the glycerol chain of sialic acid when 
modifying gangliosides. Similarly, another head group-labeled GM1 probe, in 
which the C5 amino position of sialic acid was conjugated to ATTO647N, showed 
low-level partitioning to the Lo-like phase in GPMVs [40].  
 
1.3. Behavior of ganglioside analogs in cell PMs 
1.3.1. Conjugation of hydrophilic dyes to the terminal residues of 
gangliosides to create PM raftophilic analogs 
As previously described, fluorescently labeled ganglioside-binding 
proteins have been employed as both GM1 and GM3 markers but these proteins 
are multivalent and crosslink with gangliosides. This changes the distribution and 
behavior of gangliosides in the PM. It has consequently been impossible to 
examine if gangliosides partition into rafts in either steady-state or stimulated 
cells. We therefore utilized our new fluorescent ganglioside probes to investigate 
the partitioning of these derivatives in lipid rafts. GPI-anchored proteins are 
typical markers of raft molecules and congregate in large areas after live cells are 
incubated with primary and secondary antibodies [80]. We therefore employed 
the complementary control factor CD59 as a GPI-anchored protein marker of lipid 
rafts.  
Using confocal fluorescence microscopy, we found that our new 
ganglioside probes partitioned into both the DRM and Lo-like domains, and co-
localized with large areas of CD59 staining. It is important to note that such co-
localization was observed without any clustering induced by binding proteins, 
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such as cholera toxin subunit B (CTB) or antibodies. These results indicated that 
the affinity of GM3 analogs for lipid rafts was highest for 594-S9-GM3, 488-S9-
GM3, and Fl-S9-GM3, and then affinities decreased from TMR-S9-GM3 to TMR-
G6-GM3. For GM1 analogs, 594-S9-GM1, 594-termG6-GM1, 488-S9-GM1 were all 
equivalent and had higher affinity than TMR-S9-GM1. However, 647N-S9-GM3, 
TMR-G6-GM3, and Bodipy-FL-GM1 partitioned into the non-raft fraction and 
should therefore not be used as markers for lipid rafts. Based on these data, we 
synthesized and assessed the GM2 and GD1b fluorescent probes, 594-S9-GM2, 
594-GN6-GM2, and 594-termG6-GD1b. We found that these probes were 
concentrated in induced large lipid rafts. 
 
1.3.2. Single-molecule imaging of ganglioside probes, both inside and 
outside areas stained with CD59  
Confocal fluorescence microscopy revealed that the ganglioside probes 
we have developed co-localized with rafts in PMs, but it is still unclear if these 
probes dynamically entered and left the raft domains. Single fluorescent-molecule 
tracking of 594-S9-GM3 and GM1 revealed that both probes diffused in the bulk 
and regions of CD59 staining (used as a marker of raft regions). Each ganglioside 
probe was maintained within the boundaries of CD59 patch and the bulk region, 
rather than passing through. However, the non-raft phospholipid probe 594-DOPE 
was primarily located outside of the CD59 regions and was repelled at the 
boundary of the rafts. We found that our ganglioside probes were enriched in the 
CD59-rich regions by 4- to 10-fold, while 594-DOPE was almost completely 
excluded. These data are consistent with the confocal fluorescence microscopy 
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observations and indicate that the large regions containing CD59 form raft 
domains by transiently recruiting other raft molecules, such as gangliosides.  
The 594-S9-GM3 and GM1 molecules found in the large CD59 patches 
frequently underwent temporal confinement with lifetimes of ~100 ms. We term 
this process Temporal Arrest of LateraL diffusion (TALL). Conversely, almost all 
of the 594-S9-GM3 and GM1 molecules outside of the CD59 regions were 
constantly mobile when observed at 33, 8, or 0.5 ms intervals [61]. After actin 
depolymerization, the fractions of TALL for 594-S9-GM3 and GM1 inside the CD59 
regions were significantly decreased, suggesting that antibody-induced CD59 
clusters might associate with the actin-based membrane skeleton. Alternatively, 
they may induce actin polymerization and TALL occurs through indirect (or 
transbilayer) interactions between gangliosides and actin filaments. This may be 
due the binding of gangliosides with crosslinked CD59 clusters that are 
immobilized on actin filaments via an unknown transmembrane protein, or 
interdigitation of the outer and inner leaflets [81]. 
A recent study by Sevcsik et al. (2015) showed the formation of 3 µm-
sized spots of monomeric GFP-GPI (mGFP-GPI) using an anti-GFP antibody 
coated micropattern did not lead to concentration of CD59, another GPI-anchored 
protein [82]. The density of mGFP-GPI in the micropattern varied between 
500~10,000 molecules/µm2, and occupied 0.5~11% of the area in the spots. In 
a study by Komura et al. (2016) [61], CD59 was crosslinked by primary and 
secondary antibodies, producing relatively small clusters less than 3 µm in 
diameter. These occupied 7.7~20% of the area in the cluster if the average 
distance between CD59 molecules was 9.6 nm [83] or 6.0 nm [84] and the radius 
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of CD59 was 1.5 nm [82]. Higher densities of CD59 were able to concentrate the 
ganglioside probes that Komura et al. (2016) developed [61]. This is consistent 
with the large drop in the diffusion coefficients shown for the probe molecules 
when the nearest-neighbor distance of steric obstacles was less than 10 nm [82]. 
 
1.3.3. Stabilization of GPI-anchored protein cluster rafts through 
ganglioside recruitment 
We next examined raft formation under more physiological conditions. 
After ligation, CD59 forms stable oligomers that recruit and activate intracellular 
signaling molecules, including phospholipase C (PLC), Src family kinase (SFKs), 
and trimeric G proteins [85-90]. This eventually leads to intracellular IP3-Ca2+ 
responses. These CD59 oligomers have been termed “CD59-cluster signaling rafts” 
and they form under certain physiological conditions. We performed simultaneous 
two-color single-molecule observations of fluorescent ganglioside probes (GM1 
and GM3) and the stable CD59 oligomers that are induced upon ligation.  
Both 594-S9-GM1 and GM3 probes were recruited to the stable CD59-
cluster signaling rafts where they interacted for an average of approximately 100 
ms before separating (Fig. 10a-c). However, the non-raft control phospholipid, 
594-DOPE, co-localized with CD59-cluster signaling rafts for much shorter periods 
of time. After cholesterol depletion, or when using the non-raft chimeric mutant 
protein CD59-TM, the durations of co-localization were approximately halved. 
These results indicated that the co-localization of gangliosides and CD59 was not 
due to an interaction between the headgroup regions of gangliosides and CD59 
but was rather due to raft-lipid interactions and the alkyl chains. This is supported 
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by a recent study examining sphingomyelin and saturated phosphatidylcholine 
probes [91]. 
 
1.3.4. GPI-anchored protein homodimers are stabilized by raft-lipid 
interactions 
In steady state PMs, CD59 forms transient homodimers with a mean 
lifetime of approximately 160 ms [87, 92]. The lifetime of homodimers was 
reduced by half after PM cholesterol depletion or after replacing the GPI-
anchoring chain of CD59 with a non-raft-associating transmembrane domain. 
These results suggest that CD59 homodimers are stabilized by raft-lipid 
interactions.  
Single-molecule tracking of 594-S9-GM3 and GM1 showed that 
gangliosides are transiently recruited to short-lived CD59 homodimers for 
approximately 80 ms, and to CD59 monomers for 50 ms (Fig. 10c) [61]. The non-
raft-associating control 594-DOPE co-localized with CD59 monomers and 
homodimers for an average of only 40 ms, shorter than the co-localization 
lifetimes of the gangliosides (Fig. 10c). Transient interactions between 
gangliosides and both CD59 monomers and homodimers may be due to 
interactions between glycans and/or the protein moieties of CD59 and glycans 
and/or lipid moieties. It is interesting that the associating periods of gangliosides 
and CD59 cluster rafts (approximately 100 ms) were longer than those found for 
CD59 homodimers (80 ms) and much longer than those shown by CD59 
monomers (50 ms). These results support our previous results indicating that 
CD59 cluster rafts and CD59 homodimers are stabilized by raft-lipid interactions 
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and raft-lipid interactions may be mediated or strengthened by ganglioside 
recruitment. 
It was previously unknown as to whether clustered raft molecules can 
recruit other raft components, although when additional raft elements are 
clustered, both the initial and following raft molecules co-localize with each other 
[52, 53, 80, 93]. It was also not obvious if these secondary non-crosslinked raft 
elements can be recruited to clustered raft molecules. Simultaneous single-
molecule observations of CD59 and non-crosslinked ganglioside probes have 
revealed that non-crosslinked gangliosides are transiently recruited to CD59 
monomers, CD59 homodimers, CD59-cluster signaling rafts, and CD59 regions. 
These results are consistent with another study showing that mGFP-GPI dimers 
induced by a monoclonal antibody transiently recruit other non-crosslinked GPI-
anchored proteins [94]. 
 
1.3.5. Assessment of the TALL fractions of ganglioside probes by high-
speed observations of single-molecule probes 
Previous reports have shown that ganglioside probes are temporarily 
confined in small domains in cell PMs for 10~20 ms. Conversely, control non-raft 
unsaturated phospholipid probes rarely display TALL [36, 76, 95-97]. In these 
earlier studies, the fraction of time that gangliosides were confined to the 
membrane decreased after cholesterol depletion. However, as previously outlined, 
the ganglioside probes used in this previous work partitioned into non-raft 
fractions, such as the Ld phase and non-DRMs [40, 61]. We therefore examined 
whether our new ganglioside probes partitioned into the raft fraction or were 
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confined to small domains in the PMs of cells. To achieve this, we performed 
single molecule imaging of 594-S9-GM1, 594-S9-GM3, and 594-DOPE at 0.5 ms 
intervals at 23C in PtK2, CHO-K1, T24, and NRK cell types. The TALL of various 
gangliosides were measured using previously developed methods [96] that were 
further refined through our studies [87, 98].  
 Fractions of time in which diffusion was constantly confined to small areas 
(the immobile fraction) were rarely found for all three tested molecules in each 
of the cell types. The proportions of time spent in the 100 nm diameter domains 
were estimated to be 1.7~3.1% for 594-S9-GM3 and GM1 and 4.6~5.2% for 594-
DOPE in each of the four cell types. Our new GM1 and GM3 probes were therefore 
excellent raft markers and spent little time trapped in small membrane domains. 
This was not the same for the non-raft-associating 594-DOPE control. The results 
of this investigation into our new ganglioside probes are supported by recent 
studies reporting new sphingomyelin (SM) and distearoyl phosphatidylcholine 
(DSPC) probes that partition into the Lo phase and DRM fraction. These probes 
also did not show any TALL in small domains (100 nm in diameter) when assessed 
using high-speed observations at 0.5 ms intervals [91]. However, these results 
are at odds with some previous data [36, 76, 96, 97]. For example, Sahl et al. 
(2010) [96] reported that their SM probe (ATTO647N-SM) had a TALL with a 
lifetime of 17 ms and the proportion of time the probe spent in small domains 
was approximately 70% (with an apparent trapped domain 12 nm in diameter ) 
in the basal PMs of PtK2 cells. A phospholipid analog (ATTO647N-DOPE) only 
exhibited TALL with a lifetime of 3 ms and proportion of time spent in small 
domains was 30% (with an apparent trapped domain 22 nm in diameter). We 
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used the same protocol as Sahl et al. (2010) to determine TALL using various 
means, but could only determine a short period of TALL [61, 91]. 
We also incorporated the lipid probes into cell PMs without bovine serum 
albumin (BSA) and observed single molecules in cells with low confluency (less 
than 50%). This was only possible when the fluorophore of the probe is 
hydrophilic and negatively charged because ganglioside analogs that feature 
hydrophobic dyes bind strongly to the glass apparatus, whether the probe was 
adsorbed to BSA or not (unpublished data). Additionally, the confluency of PtK2 
cells used by Sahl et al. (2010) was relatively high (cells were seeded to a 
confluency of 80% and lipid probes were observed at 100% cell confluency). As 
PtK2 cells form tight junctions at high confluencies [99], lipid probes added from 
cell apical sides accumulate in the apical membrane and are rarely observed in 
the basal membranes (unpublished data). Due to the fact Sahl et al. (2010) 
observed molecular diffusion at the basal membranes, the lipid composition and 
membrane structures they observed may be different from those examined in our 
study. This may be one of the reasons why our results differ from Sahl et al. 
(2010)[96]. 
 A large fraction of ganglioside probes underwent simple Brownian 
diffusion when observed at 0.5 ms intervals [61]. However, single-molecule 
imaging of lipids and transmembrane proteins at a higher temporal resolution, 
such as 25 µs/frame, showed a different type of motion. Briefly, the molecules 
underwent temporary confinement in a boundary region of the membrane with 
an average diameter of 30-230 nm. This confinement was interrupted by rare 
hops (1-50 ms) to adjacent, yet still temporary confining regions, that we have 
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termed compartments [100-107]. We have named this behavior hop diffusion as 
the membrane molecules undergo macroscopic diffusion by “hopping” to 
adjacent compartments, although they freely diffuse within a compartment. In 
future work to investigate the association between gangliosides, lipid rafts, and 
membrane structures in more detail, our work suggests that single ganglioside 
probe molecules should be observed at higher time resolutions. 
 
2. Conclusion 
New ganglioside probes that partition into raft domains (DRM, Lo-like 
domains, and CD59 clusters), and bind to proteins with similar affinity to the 
parental molecules, can be developed using an entirely chemical-based synthesis 
method after intensive effort [61]. The conjugation of hydrophilic fluorescent 
dyes at the appropriate positions within gangliosides (for example, the C9 
position of the sialic acid group) is essential for maintaining their properties. 
Furthermore, as non-specific binding of hydrophilic ganglioside probes to glass is 
low, they can be easily incorporated into cell PMs without complex formations 
that incorporate BSA. Single-molecule observations have revealed that the new 
ganglioside probes we have developed were transiently recruited to CD59 
monomers and short-lived homodimers in steady state cells, and also to CD59-
cluster signaling rafts and large antibody-induced CD59 patches. This is the first 
direct observation of an association between gangliosides and a GPI-anchored 
protein without involving crosslinking of gangliosides nor artifacts. This 
demonstrates that gangliosides and GPI-anchored proteins dynamically associate 
with each other in a cholesterol-dependent manner within milliseconds. These 
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results also indicated that CD59 cluster rafts and CD59 homodimers are stabilized 
by raft-lipid interactions that may be mediated or strengthened by ganglioside 
recruitment. Such a finding would not have been possible without naturally 
behaving fluorescent ganglioside analogs and single-molecule imaging. When 
gangliosides are crosslinked by proteins such as CTB and WGA, their diffusion 
slows, or even stops, and it appears that gangliosides interact with GPI-anchored 
protein clusters for very long periods of time [61].  
 Gangliosides play important roles in a wide variety of physiological 
functions, including the regulation of receptor activity. However, the specific 
mechanisms that underlie these roles are unclear because gangliosides have 
never directly been observed in living cell PMs due to a lack of functional analogs. 
The new fluorescent ganglioside probes we have developed behave similarly to 
parental molecules and will facilitate studies to elucidate these mechanisms. 
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Figure Legends 
Fig. 1. An overview of the variety of roles that gangliosides play in the 
physiological functions of cell membranes. For example, gangliosides are involved 
in the regulation of membrane receptor activity (Left), the formation of raft 
domains, of which they are one of the most important components (Middle), and 
the invasion of bacteria, microbial toxins, and viruses into cells (Right). 
 
Fig. 2. Fluorescent analogs of GM1 derived from natural GM1. 
 
Fig. 3. A fluorescent analog of GM3 synthesized using a chemoenzymatic method. 
 
Fig. 4. Fluorescent analogs of gangliosides synthesized using a chemical method. 
 
Fig. 5. Outline of the synthetic routes used to create fluorescent analogs of GM3. 
MP = p-methoxybenzyl; Bn = benzyl; Troc = 2,2,2-trichloroethoxycarbonyl; Bz = 
benzoyl; TFAc = trifluoroacetyl; PMB = p-methoxybenzyl. 
 
Fig. 6. Outline of the synthetic routes used to create fluorescent analogs of GM1. 
 
Fig. 7. Outline of the synthetic routes used to create fluorescent analogs of GM2. 
TCA = trichloroacetyl. 
 
Fig. 8. Outline of the synthetic routes used to create fluorescent analogs of GD1b. 
SE = 2-(trimethylsilyl)ethyl. 
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Fig. 9. Partitioning of fluorescent ganglioside analogs. (A) Fluorescence images 
of 594-S9-GM3, before and after treatment of T24 cells with cold-Triton X-100. 
(B) Fluorescence images of 594-S9-GM1 and BodipyFL-PC, showing how they are 
partitioned into Lo- and Ld-like domains in GPMVs. (C) The second column 
contains the ratios of the fluorescence intensities for probes that remained in cell 
PMs after cold-Triton X-100 relative to intact cell PMs. The third column contains 
the ratios of probes in the Lo phase of GPMVs relative to the Ld phase.  
 
Fig. 10. Single-molecule observations of ganglioside probes and CD59. 
Ganglioside probes were frequently and transiently recruited to CD59 homodimer 
rafts and CD59-cluster signaling rafts [43]. (A) Typical video-frame sequences of 
simultaneous observations of single 594-S9-GM3 molecules and CD59-cluster 
signaling rafts. The co-localization period was between frames 6 and 9. A time 
course is shown above the images. (B) The trajectories of single 594-S9-GM3 
molecules and CD59-cluster rafts shown in (A). Co-localization within 240 nm is 
shown in the blue (594-S9-GM3) and orange (CD59-cluster raft) trajectories. 
(C) A schematic of the transient recruitment of gangliosides (GM1 and GM3) to 
CD59 monomers, transient homodimer rafts (with a lifetime of 160 ms), and 
CD59-cluster signaling rafts continuing for 12, 40, and 48 ms. The transient 
interactions between gangliosides and each of these forms of CD59 in the PMs 
was dependent on raft-lipid interactions. Transient CD59 monomers and 
homodimers converted between each other frequently in steady-state cells. 
However, after stimulation, CD59-cluster signaling rafts formed that were highly 
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stable and lasted for several minutes. 
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